TABLE 2.
Perioperative outcomes of ESCC patients after RAMIE.
| Variables | All patients n = 201 (%) | Before matching | p | After matching | p | ||
|---|---|---|---|---|---|---|---|
| NCI, n = 58 (%) | Surgery only, n = 143 (%) | NCI, n = 55 (%) | Surgery only, n = 55 (%) | ||||
| Operation time, min, mean ± SD | 303.4 ± 55.9 | 303.4 ± 59.2 | 293.8 ± 52.9 | 0.248 | 304.4 ± 61.4 | 308.7 ± 62.7 | 0.720 |
| Surgical blood loss, mL, mean ± SD | 163.6 ± 109.9 | 153.3 ± 135.8 | 153.5 ± 87.2 | 0.992 | 152.9 ± 144.0 | 162.9 ± 96.1 | 0.669 |
| Hospital stay, days, mean ± SD | 15.1 ± 10.0 | 14.2 ± 8.6 | 14.5 ± 12.0 | 0.812 | 14.5 ± 9.1 | 15.1 ± 11.1 | 0.750 |
| Intensive care unit stay, n (%) | 14 (7.0) | 1 (1.7) | 13 (9.1) | 0.069 | 1 (1.8) | 6 (10.9) | 0.113 |
| Mortality | 1 (0.5) | 0 | 1 (0.7) | 1.000 | 0 | 1 (1.8) | 1.000 |
| Overall complications | 43 (21.4) | 12 (20.7) | 31 (21.7) | 0.565 | 11 (20.0) | 16 (29.1) | 0.171 |
| RLN paralysis | 10 (5.0) | 4 (6.9) | 6 (4.2) | 0.728 | 3 (5.5) | 1 (1.8) | 0.618 |
| Pulmonary complication | 19 (9.5) | 2 (3.4) | 17 (11.9) | 0.039 | 2 (3.6) | 8 (14.5) | 0.047 |
| Anastomotic leakages | 11 (5.5) | 2 (3.4) | 9 (6.3) | 0.508 | 2 (3.6) | 4 (7.2) | 0.679 |
| Surgical site infections | 2 (1.0) | 1 (1.7) | 1 (0.7) | 0.532 | 1 (1.8) | 1 (1.8) | 0.532 |
| Chylothorax | 5 (2.5) | 2 (3.4) | 3 (2.1) | 1.000 | 2 (3.6) | 2 (3.6) | 1.000 |
| Cardiovascular complications | 1 (0.5) | 0 | 1 (0.7) | 1.000 | 0 | 0 | 1.000 |
| VTE | 1 (0.5) | 0 | 1 (0.7) | 1.000 | 0 | 0 | 1.000 |
| Others | 5 (2.5) | 3 (5.2) | 2 (1.4) | 0.181 | 3 (5.5) | 2 (3.6) | 0.181 |
Abbreviations: ESCC, esophageal squamous cell carcinoma; NCI, neoadjuvant chemoimmunotherapy; RAMIE, robot‐assisted minimally invasive esophagectomy; RLN, recurrent laryngeal nerve; SD, standard deviation; VTE, venous thromboem.